CUSIP 81734D104COMSEPNQ4 2025
10 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 7.00M | $195.04M |
| 2 | Trv Gp V, LLC | 6.22M | $173.29M |
| 3 | Driehaus Capital Management LLC | 4.81M | $134.09M |
| 4 | Trv Gp Vi, LLC | 4.21M | $117.42M |
| 5 | Samsara Biocapital, LLC | 3.15M | $87.80M |
| 6 | Goldman Sachs Group Inc | 2.72M | $75.70M |
| 7 | Siren, L.L.C. | 2.00M | $55.76M |
| 8 | Blackrock, Inc. | 1.80M | $50.22M |
| 9 |
| 4 | May 15, 2025 | Biotechnology Value Fund L P | 13G/A | 9.9% | 4.40M | SEC |
| 5 | May 9, 2025 | Third Rock Ventures V, L.P. | 13G/A | 14.0% | 6.22M | SEC |
| 6 | Feb 14, 2025 | Driehaus Capital Management LLC | 13G | 5.8% | 2.59M | SEC |
| 7 | Feb 13, 2025 | Third Rock Ventures V, L.P. | 13G | 14.0% | 6.22M | SEC |
| 8 | Nov 4, 2024 | Ra Capital Management, L.P. | 13D | 15.8% | 7.00M | SEC |
| 9 | Nov 4, 2024 | Samsara Biocapital, L.P. | 13G | 6.2% | 2.77M | SEC |
| 10 | Nov 1, 2024 | Biotechnology Value Fund L P | 13G | 2.9% | 1.30M | SEC |
| 1.72M |
| $47.98M |
| 10 | Vanguard Group Inc | 1.51M | $42.05M |